i came across open access article twitter feed highlights reality antidepressants i trying get previous post i encourage full reading article order understand specifically patients selected large commercial database retrospective study authors selected patient diagnosis major depressive disorder mdd taking antidepressant specific time interval purpose constructing survival curve started group people antidepressants ended excluding exclusions based diagnosis mdd previous months prescription ad previous months lack continuous enrollment previous months pharmacological therapies included initiating treatment one ad ads augmenting agents aa final study population patients two major endpoints defined measures medication adherence medication possession ratio mpr proportion days covered pdc pdc considered primary measure adherence due previous convention calculations made months persistence adherence calculated major antidepressant class ssri snri tca maoi adherence persistence calculated across dimensions bar graphs available full text adherence persistence months snris highest persistence adherence rates months tcas lowest looking kaplan meier survival curves significantly different lowest adherence initial tca maoi therapy curves also show natural break points day intervals correspond typical length prescriptions although primary care physicians provide significant number refills beyond study like obvious limitations authors good job explaining limitations using database like one limited granularity example data status prescriber practice context i would question whether adherence different among given antidepressant based screening questionnaire versus detailed assessment follow would also interesting see subjects seeing psychiatrists adherent i guessing majority patients see primary care surrogate markers psychiatric care could devised based ad aa combinations would imperfect marker since primary care depression guidelines incorporate strategies minor erratum essentially typographic error change main paper i look study like i always ask myself study group resembles people i currently seeing seen case population female covered commercial insurance twenty four percent comorbid anxiety comorbid chronic noncancer pain sertraline largest percentage prescriptions people bupropion extended release i currently see large number people sertraline citalopram bupropion augmentation despite fda warning maximum doses citalopram i still see people mg day mg day years age older situations flagged fda warning i find snri medication better tolerated ssri hesitate make change sooner later give limitations interesting study several levels matches experience least people tolerate ssris well i also found snris effective well tolerated snris major limitation perspective without data authors refer really possible design clinical program optimized adherence provides much foundation differences many psychiatrists experience see people severe depression years many cases plasma levels antidepressants measure optimize dosing also confirm adherence cases patients settings medications administered critical dimension psychiatric practice ongoing relationship patient looking relationship patient effects adherence needed obviously difficult study capture retrospective database george dawson md dfapa references keyloun kr hansen rn hepp z gillard p thase me devine eb adherence persistence across antidepressant therapeutic classes retrospective claims analysis among insured patients major depressive disorder mdd cns drugs may doi pubmed pmid keyloun kr hansen rn hepp z gillard p thase me devine eb erratum adherence persistence across antidepressant therapeutic classes retrospective claims analysis among insured patients major depressive disorder mdd cns drugs apr doi epub ahead print pubmed pmid attribution graphic directly reference reposted per terms attribution noncommercial international nc license changes made graphic click graphic enlarge thanks barney carroll putting reference twitter feed